Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Other | $280.7K | SEC | |
| ExerciseD | $0 | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | — | SEC | |
| OtherD | $0 | SEC | |
| Other | $791.6K | SEC | |
| Exercise | — | SEC | |
| ExerciseD | $0 | SEC | |
| Other | $776K | SEC | |
| Other | $747.9K | SEC | |
| Exercise | — | SEC | |
| AwardD | $0 | SEC | |
| Exercise | — | SEC | |
| ExerciseD | $0 | SEC | |
| Buy | $20.5K | SEC | |
| Buy | $8.2K | SEC | |
| Buy | $61.2K | SEC | |
| Buy | $41.4K | SEC | |
| Buy | $12.4K | SEC | |
| Buy | $41.3K | SEC | |
| Buy | $61.4K | SEC | |
| ExerciseD | $0 | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | — | SEC | |
| Exercise | — | SEC |